E
ELDN
Eledon Pharmaceuticals Inc
3.200
-0.020-0.62%Pre Market: 3.230 +0.030 +0.94%08:03 04/15 EDT
OPEN/PREV CLOSE3.255/3.220
TODAY RANGE3.140-3.310
VOL965
MARKET CAP242.73M
52 WEEK RANGE1.350-4.600
AVG VOL (3M)1.07M
% TURNOVER1.20%
TURNOVER0
P/E (TTM)-5.7409
% RANGE5.28%
EPS(TTM)-0.5574
P/E(FORWARD)-3.4043
P/B1.765
BVPS1.813
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP239.93M
SHARES OUTSTANDING75.85M
NEXT EARNINGS05/12-05/18
FREE FLOAT74.98M
LOT SIZE1
EX-DATE10/05/2020
News
Press Releases
Financial Reports
Profile
Seeking Alpha·03/19 21:21
Eledon Pharmaceuticals GAAP EPS of -$0.52 beats by $0.15
Reuters·03/19 21:19
Eledon Pharmaceuticals 2025 net loss widens on higher R&D costs
Benzinga·03/19 21:13
Eledon Pharma Q4 EPS $(0.10) Beats $(0.18) Estimate
Dow Jones·03/19 21:11
*Eledon Pharmaceuticals 2025 Loss/Shr 52c >ELDN
Reuters·03/19 21:10
ELEDON PHARMACEUTICALS FY NET INCOME USD -45.617 MILLION
Dow Jones·03/19 21:10
Press Release: Eledon Pharmaceuticals Reports -2-
Reuters·03/19 21:06
Eledon FY2025 net loss widened 26% to USD 45.62 million
Reuters·03/19 21:05
ELEDON PHARMACEUTICALS: Q4 EPS $-0.52
Seeking Alpha·03/16 20:50
Eledon sees promising data for tegoprubart in islet transplant type 1 diabetes.
Same Industry
Name/Symbol
Change%
Price